| 2024/11/08 17:56:29 | |
|---|---|
| Price | |
| 145.86 EUR | |
| Difference | -0.72% (-1.06) |
General attributes
| ISIN | US4781601046 |
| Symbol | JNJ |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Consumer Products |
| Security type | Stock |
| Market cap (m) | 349,514 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 144.96 EUR (600) |
| Ask (Ask size) | 145.16 EUR (600) |
| Open | 145.22 EUR |
| High | 145.86 EUR |
| Low | 145.22 EUR |
| Close (prev. day) | 146.92 EUR |
| VWAP | 106.40 EUR |
| Volume (pcs) | 15 |
| Trading volume | 2,187.90 |
| Number of trades | 2 |
| Last size | 15 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: JOHNSON & JOHNSON |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/11/05 |
|
Global Equity Ratings |
|
| 2024/10/29 |
|
Global Equity Ratings |
|
| 2024/10/22 |
|
Global Equity Ratings |
|
| 2024/09/27 |
|
Global Equity Ratings |
|
| 2024/09/11 |
|
Global Equity Ratings |
|
| 2024/11/08 17:56:29 | |
|---|---|
| Price | |
| 145.86 EUR | |
| Difference | -0.72% (-1.06) |
General attributes
| ISIN | US4781601046 |
| Symbol | JNJ |
| Exchange | Berlin |
| Currency | EUR |
| Sector | Consumer Products |
| Security type | Stock |
| Market cap (m) | 349,514 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 144.96 EUR (600) |
| Ask (Ask size) | 145.16 EUR (600) |
| Open | 145.22 EUR |
| High | 145.86 EUR |
| Low | 145.22 EUR |
| Close (prev. day) | 146.92 EUR |
| VWAP | 106.40 EUR |
| Volume (pcs) | 15 |
| Trading volume | 2,187.90 |
| Number of trades | 2 |
| Last size | 15 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +5.44% | +3.52% | +3.20% |
| Perf (abs.) | +7.52 | +4.96 | +4.52 |
| Beta | -0.19 | -0.01 | 0.25 |
| Volatility | 15.38 | 14.85 | 17.48 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 146.60 EUR (3) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 147.81 EUR (9) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 145.20 EUR (9) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 143.41 EUR (14) |
| YTD High | date | 153.10 EUR (2024/10/24) |
| YTD Low | date | 132.80 EUR (2024/05/29) |
| 52 Weeks High | date | 153.10 EUR (2024/10/24) |
| 52 Weeks Low | date | 132.80 EUR (2024/05/29) |
All listings for JOHNSON & JOHNSON
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/11/08 | 17:35 | 145.70 EUR | 0.29 | 75 |
| Vienna Stock Exchange | 2024/11/08 | 17:32 | 145.60 EUR | 0.00 | 6 |
| Tradegate | 2024/11/08 | 22:26 | 145.10 EUR | 0.73 | 137 |
| Stuttgart | 2024/11/08 | 21:31 | 145.32 EUR | 0.00 | 8 |
| SIX Swiss Exchange | 2023/03/01 | 17:36 | 500.00 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2023/05/25 | 17:36 | 136.00 USD | 0.00 | 1 |
| NYSE | 2024/11/08 | 22:00 | 155.47 USD | 1,374.80 | 120,235 |
| Munich | 2024/11/08 | 16:29 | 145.62 EUR | 0.01 | 3 |
| London Stock Exchange | 2024/11/08 | 17:35 | 156.20 USD | 0.02 | 13 |
| Hanover | 2024/11/08 | 17:25 | 145.48 EUR | 0.00 | 4 |
| Hamburg | 2024/11/08 | 17:25 | 145.50 EUR | 0.00 | 2 |
| Frankfurt | 2024/11/08 | 19:22 | 145.86 EUR | 0.06 | 11 |
| Euronext Milan MTF Trading After Hours | 2024/11/04 | 18:11 | 145.22 EUR | 0.01 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/11/08 | 17:44 | 145.64 EUR | 0.01 | 2 |
| Duesseldorf | 2024/11/08 | 19:30 | 145.54 EUR | 0.00 | 7 |
| Berlin | 2024/11/08 | 17:56 | 145.86 EUR | 0.00 | 2 |
Company Logo
Contact Details
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon: +1-732-524-0400 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: JOHNSON & JOHNSON | |
Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. |
Members of Management Board
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Paula Johnson | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Eugene Woods | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph J. Wolk | Member of Executive Committee |
| Kathy Wengel | Member of Executive Committee |
| Liz Forminard | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |